Ampacet Releases New Medical Laser Marking Portfolio
The new ProVital+ LaserMark masterbatches offer biocompatible solutions for high-contrast marking on medical plastics.
Updated on Oct. 20, 2026 in Materials Science
Live Poll
Do you believe advancements in medical material technology effectively increase overall patient safety?
Ampacet has launched the ProVital+ LaserMark masterbatch portfolio, a collection of materials engineered for high-contrast laser marking on medical devices and packaging. These products aim to improve safety and regulatory compliance through specialized, biocompatible formulations.
Why it matters
Medical device marking is essential for maintaining product safety and manufacturing efficiency. By providing pre-tested materials, this technology helps manufacturers meet strict regulatory standards for equipment and diagnostic tools.
The masterbatches are validated for biocompatibility under ISO 10993 parts 5, 10, and 23 and meet European Pharmacopeia 11th edition, monograph 3.1.3 standards. The line includes product 1001514-EM, which features an antimony-free chemical formulation.
The players
Ampacet
Ampacet is a global masterbatch leader that provides color, additive, and functional masterbatches for the plastics industry.
The details
The portfolio uses raw materials pre-evaluated for cytotoxicity, skin sensitization, and irritation to support healthcare applications. These masterbatches are designed for Nd:YAG laser systems to create clear, durable identification on polyethylene and polypropylene parts.
Timeline
Ampacet released the ProVital+ LaserMark portfolio on October 20, 2026.
The Big Picture
This development follows the rigorous safety benchmarks set by ISO 10993 standards to ensure medical device materials are safe for human contact. By integrating these testing requirements into the manufacturing process, the product bridges the gap between raw plastic material science and strict clinical safety regulations.
Healthcare manufacturers can utilize these pre-tested materials to simplify the regulatory approval process for new medical equipment. This could lead to faster production times for medical packaging and components while ensuring high-quality, permanent labeling for patient safety.
The takeaway
Manufacturers of medical devices should consider using pre-verified masterbatches to reduce the burden of individual material biocompatibility testing. Implementing standardized marking solutions helps companies maintain reliable product tracking throughout the entire medical supply chain.
Further reading
For broader trends in material engineering, explore the Materials Science section.
Source note: This article includes information reported by Interplas Insights.
Live Poll
Do you believe advancements in medical material technology effectively increase overall patient safety?
